指南与共识肾癌与肾肿瘤

T1肾肿瘤手术治疗对指南的依从性与医院手术量相关:英国泌尿外科医师协会肾切除术审计分析

Guideline adherence for the surgical treatment of T1 renal tumours correlates with hospital volume: an analysis from the British Association of Urological Surgeons Nephrectomy Audit.
指南 / 共识 · BJU Int · 2019-08-18

基于英国泌尿外科医师协会肾切除术审计2012—2016年数据,回顾性分析13 045例T1肾肿瘤手术。偏部分肾切除术(PN)使用率从2012年39.7%升至2016年44.9%,年手术量<25例中心PN比例18.1%,≥100例中心61.8%;总并发症与主要并发症率随手术量增加而降低。作者认为结果支持肾癌专科手术服务集中化以改善患者结局。

要点

  • T1肾肿瘤PN使用率由2012年39.7%升至2016年44.9%。
  • 年手术量<25例中心PN比例18.1%,≥100例中心61.8%。
  • 总并发症率低容量中心12.2% vs 高容量中心10.7%,主要并发症2.9% vs 2.2%。

核心结论

  • 高手术量中心对指南的依从性更好,T1肿瘤PN使用随医院手术量增加而增加,且医院手术量与并发症率呈反向关联。
  • 作者认为这些结果支持将肾癌专科手术服务集中化以改善患者结局。

研究设计与样本

  • 回顾性分析英国泌尿外科医师协会肾切除术审计中2012—2016年所有接受根治性肾切除术(RN)或部分肾切除术(PN)的肾脏肿瘤数据。
  • 共纳入13 045例经手术治疗的T1肿瘤,评估每中心总手术量(RN与PN)、PN率、并发症率及数据完整性。
  • 采用描述性分析,以置信区间展示医院手术量与PN比例的关系,用卡方检验和Cochran-Armitage趋势检验评估差异与趋势。

主要发现

  • PN使用率从2012年39.7%上升至2016年44.9%。
  • 术前解剖复杂性PADUA评分登记自2016年3月起纳入,39%的病例有记录。
  • 术后并发症信息缺失在各年保持稳定(8.5%—9%)。
  • 年手术量与T1肿瘤接受PN而非RN的比例存在明确关联:年手术量<25例(最低容量)中心为18.1%,≥100例(高容量)中心为61.8%,校正PADUA复杂性后关联持续存在。
  • 总体并发症率和主要并发症率(Clavien-Dindo分级≥III)随医院手术量增加而降低:低容量中心分别为12.2%和2.9%,高容量中心分别为10.7%和2.2%,适用于包括接受PN在内的所有患者。

临床怎么用

  • 作者认为结果支持将肾癌专科手术服务集中化以改善患者结局。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess European Association of Urology guideline adherence on the surgical management of patients with T1 renal tumours and the effects of centralisation of care. PATIENTS AND METHODS: Retrospective data from all kidney tumours that underwent radical nephrectomy (RN) or partial nephrectomy (PN) in the period 2012-2016 from the British Association of Urological Surgeons Nephrectomy Audit were retrieved and analysed. We assessed total surgical hospital volume (HV; RN and PN performed) per centre, PN rates, complication rates, and completeness of data. Descriptive analyses were performed, and confidence intervals were used to illustrate the association between hospital volume and proportion of PN. Chi- squared and Cochran-Armitage trend tests were used to evaluate differences and trends. RESULTS: In total, 13 045 surgically treated T1 tumours were included in the analyses. Over time, there was an increase in PN use (39.7% in 2012 to 44.9% in 2016). Registration of the Preoperative Aspects and Dimensions Used for an Anatomical (PADUA) complexity score was included in March 2016 and documented in 39% of cases. Missing information on postoperative complications appeared constant over the years (8.5-9%). A clear association was found between annual HV and the proportion of T1 tumours treated with PN rather than RN (from 18.1% in centres performing <25 cases/year [lowest volume] to 61.8% in centres performing ≥100 cases/year [high volume]), which persisted after adjustment for PADUA complexity. Overall and major (Clavien-Dindo grade ≥III) complication rate decreased with increasing HV (from 12.2% and 2.9% in low-volume centres to 10.7% and 2.2% in high-volume centres, respectively), for all patients including those treated with PN. CONCLUSION: Closer guideline adherence was exhibited by higher surgical volume centres. Treatment of T1 tumours using PN increased with increasing HV, and was accompanied by an inverse association of HV with complication rate. These results support the centralisation of kidney cancer specialist cancer surgical services to improve patient outcomes.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Tran MGB, Aben KKH, Werkhoven E, et al. Guideline adherence for the surgical treatment of T1 renal tumours correlates with hospital volume: an analysis from the British Association of Urological Surgeons Nephrectomy Audit. BJU Int. 2019. PMID: 31293036. doi:10.1111/bju.14862

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。